• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Optimal Duration of Adjuvant Chemotherapy for Gastric Cancer: Might Less Be More?

作者信息

Han Hye Sook

机构信息

Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Korea.

出版信息

J Gastric Cancer. 2022 Apr;22(2):79-82. doi: 10.5230/jgc.2022.22.e13.

DOI:10.5230/jgc.2022.22.e13
PMID:35534445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9091460/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec9e/9091460/a2dad783869b/jgc-22-79-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec9e/9091460/a2dad783869b/jgc-22-79-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec9e/9091460/a2dad783869b/jgc-22-79-g001.jpg

相似文献

1
Optimal Duration of Adjuvant Chemotherapy for Gastric Cancer: Might Less Be More?胃癌辅助化疗的最佳疗程：少是否即多？
J Gastric Cancer. 2022 Apr;22(2):79-82. doi: 10.5230/jgc.2022.22.e13.
2
Adjuvant Treatments for Localized Advanced Gastric Cancer: Differences among Geographic Regions.局部晚期胃癌的辅助治疗：不同地理区域之间的差异
Am Soc Clin Oncol Educ Book. 2012:e31-4. doi: 10.14694/EdBook_AM.2012.32.17.
3
The association between the duration of fluoropyrimidine-based adjuvant chemotherapy and survival in stage II or III gastric cancer.基于氟嘧啶的辅助化疗疗程与II期或III期胃癌患者生存率之间的关联。
World J Surg Oncol. 2016 Apr 2;14:102. doi: 10.1186/s12957-016-0845-1.
4
Optimal duration of fluorouracil-based adjuvant chemotherapy for patients with resectable gastric cancer.可切除胃癌患者基于氟尿嘧啶的辅助化疗的最佳持续时间。
PLoS One. 2013 Dec 26;8(12):e83196. doi: 10.1371/journal.pone.0083196. eCollection 2013.
5
Perioperative chemotherapy for resectable gastric cancer: MAGIC and beyond.可切除胃癌的围手术期化疗：MAGIC研究及其他。
World J Gastroenterol. 2015 Jun 28;21(24):7343-8. doi: 10.3748/wjg.v21.i24.7343.
6
Impact of duration of adjuvant chemotherapy in radically resected patients with T4bN1-3M0/TxN3bM0 gastric cancer.辅助化疗持续时间对T4bN1 - 3M0/TxN3bM0期胃癌根治性切除患者的影响。
World J Gastrointest Oncol. 2018 Jan 15;10(1):31-39. doi: 10.4251/wjgo.v10.i1.31.
7
The effect of adjuvant chemotherapy on stage IV (T4N1-3M0 and T1-3N3M0) gastric cancer.辅助化疗对 IV 期（T4N1-3M0 和 T1-3N3M0）胃癌的影响。
Cancer Res Treat. 2009 Mar;41(1):19-23. doi: 10.4143/crt.2009.41.1.19. Epub 2009 Mar 31.
8
Factors related to patient propensity to receive adjuvant chemotherapy and outcomes in stage III gastric cancer cases after D2 surgery.D2 手术后接受辅助化疗的 III 期胃癌患者的倾向性及结局的相关因素。
Asian J Surg. 2019 May;42(5):604-612. doi: 10.1016/j.asjsur.2018.08.001. Epub 2018 Sep 22.
9
Update of adjuvant chemotherapy for resected gastric cancer.胃癌辅助化疗的更新。
J Gastric Cancer. 2012 Mar;12(1):3-6. doi: 10.5230/jgc.2012.12.1.3. Epub 2012 Mar 30.
10
[A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].基于真实世界数据的胃癌围手术期化疗多中心回顾性研究
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 May 25;24(5):403-412. doi: 10.3760/cma.j.cn.441530-20200111-00014.

本文引用的文献

1
Efficacy of Different Number of XELOX or SOX Chemotherapy Cycles After D2 Resection for Stage III Gastric Cancer.D2 根治术后不同化疗周期数的 XELOX 或 SOX 方案化疗对 III 期胃癌的疗效
J Gastric Cancer. 2022 Apr;22(2):107-119. doi: 10.5230/jgc.2022.22.e11.
2
A Comprehensive and Comparative Review of Global Gastric Cancer Treatment Guidelines.全球胃癌治疗指南的全面比较性综述
J Gastric Cancer. 2022 Mar;22(1):3-23. doi: 10.5230/jgc.2022.22.e10. Epub 2022 Mar 31.
3
Adjuvant chemotherapy is an additional option for locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy: a retrospective control study.
辅助化疗是根治性胃切除加 D2 淋巴结清扫术后局部进展期胃癌的另一种选择：一项回顾性对照研究。
BMC Cancer. 2021 Aug 30;21(1):974. doi: 10.1186/s12885-021-08717-4.
4
5-Fu-Based Doublet Regimen in Patients Receiving Perioperative or Postoperative Chemotherapy for Locally Advanced Gastric Cancer: When to Start and How Long Should the Regimen Last?基于5-氟尿嘧啶的双药联合方案用于局部进展期胃癌患者围手术期或术后化疗：何时开始以及该方案应持续多长时间？
Cancer Manag Res. 2021 Jan 11;13:147-161. doi: 10.2147/CMAR.S285361. eCollection 2021.
5
A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial.一项比较辅助性单药 S1、S-1 联合奥沙利铂与术后 S-1 和奥沙利铂放化疗在接受 D2 根治术后淋巴结阳性胃癌患者中的随机 III 期临床试验：ARTIST2 试验。
Ann Oncol. 2021 Mar;32(3):368-374. doi: 10.1016/j.annonc.2020.11.017. Epub 2020 Dec 3.
6
Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach.《2018年韩国胃癌诊疗指南：基于证据的多学科方法》
J Gastric Cancer. 2019 Mar;19(1):1-48. doi: 10.5230/jgc.2019.19.e8. Epub 2019 Mar 19.
7
Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial.多西他赛联合口服氟嘧啶可提高 III 期胃癌患者的疗效：JACCRO GC-07 随机对照试验的中期分析。
J Clin Oncol. 2019 May 20;37(15):1296-1304. doi: 10.1200/JCO.18.01138. Epub 2019 Mar 29.
8
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer.III期结肠癌辅助化疗的疗程
N Engl J Med. 2018 Mar 29;378(13):1177-1188. doi: 10.1056/NEJMoa1713709.
9
Chemotherapy-induced neuropathy: A comprehensive survey.化疗诱导性神经病：全面调查。
Cancer Treat Rev. 2014 Aug;40(7):872-82. doi: 10.1016/j.ctrv.2014.04.004. Epub 2014 Apr 18.
10
Optimal duration of fluorouracil-based adjuvant chemotherapy for patients with resectable gastric cancer.可切除胃癌患者基于氟尿嘧啶的辅助化疗的最佳持续时间。
PLoS One. 2013 Dec 26;8(12):e83196. doi: 10.1371/journal.pone.0083196. eCollection 2013.